NCT03126916 2026-02-27Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Children's Oncology GroupPhase 3 Recruiting750 enrolled
NCT06528496 2026-02-10N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaMemorial Sloan Kettering Cancer CenterPhase 2 Recruiting45 enrolled